Literature DB >> 1921719

Ophthalmic findings in maple syrup urine disease.

J P Burke1, M O'Keefe, R Bowell, E R Naughten.   

Abstract

Maple Syrup Urine Disease is an autosomal recessive disorder of branched chain amino acid metabolism with an incidence in Ireland of one in 140,154 births. Ocular complications in untreated or late diagnosed patients includes optic atrophy, grey optic papilla, nystagmus, ophthalmoplegia, strabismus and cortical blindness. Seven patients with maple syrup urine disease were studied. All were diagnosed with the aid of newborn screening and commenced on early dietary treatment (mean age at diet introduction = 5 days). All remain physically well, with average intellectual performance, three having minor neurological defects and one strabismus. Early diagnosis, proper therapy and subsequent vigilant management may reduce substantially the risks of ophthalmic complications in this rare disease.

Entities:  

Mesh:

Year:  1991        PMID: 1921719

Source DB:  PubMed          Journal:  Metab Pediatr Syst Ophthalmol (1985)        ISSN: 0882-889X


  2 in total

1.  The longest-surviving patient with classical maple syrup urine disease.

Authors:  Carel le Roux; Elaine Murphy; Maggie Lilburn; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

2.  Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment.

Authors:  Menelaos G Kanakis; Helen Michelakakis; Petros Petrou; Chrysanthi Koutsandrea; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-10-03       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.